KR100856996B1 - 디아릴메틸피페라진 유도체의 신규한 비대칭 제조 방법 및중간체로서의 신규한 비대칭 디아릴메틸아민 - Google Patents

디아릴메틸피페라진 유도체의 신규한 비대칭 제조 방법 및중간체로서의 신규한 비대칭 디아릴메틸아민 Download PDF

Info

Publication number
KR100856996B1
KR100856996B1 KR1020037011675A KR20037011675A KR100856996B1 KR 100856996 B1 KR100856996 B1 KR 100856996B1 KR 1020037011675 A KR1020037011675 A KR 1020037011675A KR 20037011675 A KR20037011675 A KR 20037011675A KR 100856996 B1 KR100856996 B1 KR 100856996B1
Authority
KR
South Korea
Prior art keywords
formula
compound
methyl
reacting
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020037011675A
Other languages
English (en)
Korean (ko)
Other versions
KR20030080075A (ko
Inventor
윌리암 브라운
니클라스 플로벡
Original Assignee
아스트라제네카 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스트라제네카 아베 filed Critical 아스트라제네카 아베
Publication of KR20030080075A publication Critical patent/KR20030080075A/ko
Application granted granted Critical
Publication of KR100856996B1 publication Critical patent/KR100856996B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020037011675A 2001-03-07 2002-03-05 디아릴메틸피페라진 유도체의 신규한 비대칭 제조 방법 및중간체로서의 신규한 비대칭 디아릴메틸아민 Expired - Fee Related KR100856996B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100764A SE0100764D0 (sv) 2001-03-07 2001-03-07 New assymetric process
SE0100764-0 2001-03-07
PCT/SE2002/000376 WO2002070492A1 (en) 2001-03-07 2002-03-05 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates

Publications (2)

Publication Number Publication Date
KR20030080075A KR20030080075A (ko) 2003-10-10
KR100856996B1 true KR100856996B1 (ko) 2008-09-04

Family

ID=20283236

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037011675A Expired - Fee Related KR100856996B1 (ko) 2001-03-07 2002-03-05 디아릴메틸피페라진 유도체의 신규한 비대칭 제조 방법 및중간체로서의 신규한 비대칭 디아릴메틸아민

Country Status (20)

Country Link
US (2) US7045625B2 (https=)
EP (1) EP1368325B1 (https=)
JP (1) JP2004522793A (https=)
KR (1) KR100856996B1 (https=)
CN (2) CN1295217C (https=)
AT (1) ATE406354T1 (https=)
BR (1) BR0207817A (https=)
CA (1) CA2440104A1 (https=)
DE (1) DE60228548D1 (https=)
DK (1) DK1368325T3 (https=)
ES (1) ES2311050T3 (https=)
IL (1) IL157460A0 (https=)
MX (1) MXPA03007889A (https=)
NO (1) NO325156B1 (https=)
NZ (1) NZ527656A (https=)
PT (1) PT1368325E (https=)
SE (1) SE0100764D0 (https=)
SI (1) SI1368325T1 (https=)
WO (1) WO2002070492A1 (https=)
ZA (1) ZA200306448B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114560781A (zh) * 2022-03-01 2022-05-31 无锡捷化医药科技有限公司 一种n,n-二(2-氯乙基)-4-硝基苯基丙氨酸甲酯的制备方法
CN114702457A (zh) * 2022-03-30 2022-07-05 青岛科技大学 一种二芳基甲胺类化合物的绿色合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045637A2 (en) * 1999-12-20 2001-06-28 Astrazeneca Ab Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
CN1054850C (zh) * 1993-07-30 2000-07-26 德尔塔药物公司 用于治疗的哌嗪化合物
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045637A2 (en) * 1999-12-20 2001-06-28 Astrazeneca Ab Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides

Also Published As

Publication number Publication date
IL157460A0 (en) 2004-03-28
EP1368325A1 (en) 2003-12-10
CN1721407A (zh) 2006-01-18
CA2440104A1 (en) 2002-09-12
SE0100764D0 (sv) 2001-03-07
NO20033944L (no) 2003-10-31
BR0207817A (pt) 2004-03-09
JP2004522793A (ja) 2004-07-29
WO2002070492A1 (en) 2002-09-12
ZA200306448B (en) 2004-09-08
NO325156B1 (no) 2008-02-11
CN1244565C (zh) 2006-03-08
ES2311050T3 (es) 2009-02-01
CN1295217C (zh) 2007-01-17
MXPA03007889A (es) 2003-12-04
US7045625B2 (en) 2006-05-16
EP1368325B1 (en) 2008-08-27
DK1368325T3 (da) 2008-11-24
KR20030080075A (ko) 2003-10-10
US20060074238A1 (en) 2006-04-06
US20040077861A1 (en) 2004-04-22
SI1368325T1 (sl) 2008-12-31
HK1059436A1 (en) 2004-07-02
NO20033944D0 (no) 2003-09-05
NZ527656A (en) 2005-04-29
ATE406354T1 (de) 2008-09-15
DE60228548D1 (de) 2008-10-09
PT1368325E (pt) 2008-10-27
US7423154B2 (en) 2008-09-09
CN1494532A (zh) 2004-05-05

Similar Documents

Publication Publication Date Title
IL275584B1 (en) A process for separating a serial mixture of nicotine
KR101379154B1 (ko) 카르보닐 비대칭 알킬화
JP2004508375A (ja) 4−(N−アルキルアミノ)−5,6−ジヒドロ−4H−チエン−(2,3−b)−チオピラン−2−スルホンアミド−7,7−ジオキシドおよび中間体を得る方法
KR100856996B1 (ko) 디아릴메틸피페라진 유도체의 신규한 비대칭 제조 방법 및중간체로서의 신규한 비대칭 디아릴메틸아민
CZ20014548A3 (cs) Příprava substituovaných piperidin-4-onů
RU2134263C1 (ru) Способ получения промежуточных соединений, используемых для синтеза ингибиторов вич-протеазы
CA1069505A (en) Process for preparing 1-polyhaloalkyl-3, 4-dihydro-2-(1h)-quinazolinones
AU2002235081B2 (en) New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
CA2468426A1 (en) Process for preparing n-(4'-cyano-3'-trifluoromethylphenyl)-3-(4"-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide
AU2002235081A1 (en) New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
HK1059436B (en) New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
JP2009525972A (ja) 窒素のα位にキラル炭素があるラセミ誘導体の光学異性体分離方法
HUP0200327A2 (en) Novel method for preparing chiral amino acids
US6350902B2 (en) Process for the selective N-formylation of N-hydroxylamines
JP3740886B2 (ja) オキサゾリジン−2−オン類の製造方法
JP2000178253A (ja) 光学活性ピペコリン酸の製造法
CN102046602A (zh) 制备孟鲁司特中间体的方法
US20010031896A1 (en) Process for the selective N-formylation of N-hydroxylamines
EP0726897A1 (en) Process for the preparation of n-4- (substituted phenyl)alkylthienyl]-, and n-4- (substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
JPH08319265A (ja) N−メチル−メトキシイミノ酢酸アミド誘導体の製造法およびその中間体
CN104961670B (zh) 一种n,o‑双取代的酮亚胺衍生物的制备方法
JP2003183216A (ja) キラルなα−ヒドロキシカルボン酸の製造法
JP2003504357A (ja) イミダゾリジン−2−オン誘導体の製法
WO2004082565A2 (en) Asymmetric cyclization in the presence of substituted pseudophedrines
JPH03232871A (ja) ベンゾオキサジン誘導体の製法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20110830

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20110830

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000